Oct. 18-21 was supposed to be a four-day public meeting event, held by the EPA, to discuss if glyphosate is safe. The EPA Scientific Advisory Panel decided to postpone the meetings after heavy lobbying by the agrichemical industry.
Another sign of industry influence over @EPA as @MonsantoCo #glyphosate cancer review delayed https://t.co/p6aSGZinCK via @HuffPostGreen
— carey gillam (@careygillam) October 19, 2016
Biotech companies, including Monsanto, have all influenced the EPA in postponing these important and necessary meetings, saying the speakers will be too biased.
“EPA should replace Dr. Infante with an epidemiologist without such patent bias,” CropLife, which represents the interests of Monsanto and other agribusinesses, told the EPA.
Get NationofChange in your inbox
Independent reporting every weekday. No paywall, no advertisers, no corporate owner. Free, and you can unsubscribe whenever you like.
Subscribe free
Your gift is being matched, up to $2,000.
A member of the NationofChange board is matching every contribution to our summer drive, dollar for dollar, until the $2,000 is used up or the drive ends on 24 August. We take no advertising money and answer to no corporate owner. The article you just read was paid for by readers, and right now what they give counts twice.
COMMENTS